KAZIA THERAPEUTICS LTD Funding: $55.25M Raised (Form D)

Keep reading

More on the people and the money behind KAZIA THERAPEUTICS LTD, from the filings we hold.

Raised through the same sales agent

T.R. Winston & Company LLC received sales compensation on this raise and on 1 other raise we hold, nearest in date first:

RenovoRx, Inc. ($10M, Apr 2026)

What do you want to do with KAZIA THERAPEUTICS LTD?

What the filing says

Offered: $55,251,088. Sold: $55,251,088. Left to sell: nothing, all of it is sold. (filing)
Investors: 65 had already invested. (filing)
Date of first sale: December 3, 2025. (filing)
Types of securities: Equity; Options, warrants or other rights to acquire another security; Securities to be acquired on exercise of an option, warrant or other right. (filing)
Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)
On the amounts offered and sold: the filing adds “Includes pre-funded warrants for 938,490 ADSs, each representing 500 ordinary shares, and their aggregate exercise price at $0.0001 per ADS; and aggregate exercise price of warrants to placement agent for 700,013 ADSs at exercise price $7.5 per ADS.” (filing)
On sales commissions and finders' fees: the filing adds “The amount reflects placement agent fee of up to 7% of the gross proceeds. In addition, placement agent also received warrants to purchase up to 700,013 ADSs at an exercise price of $7.50 per ADSs.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on KAZIA THERAPEUTICS LTD See pricing

Filing history · 4 filings on this registrant

Each marker is one filing. The larger marker is the filing this page is about.

Biotechnology · by week

Trailing twelve months. 759 filings in Biotechnology, totalled by week. The dot is this raise, $55.25M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on KAZIA THERAPEUTICS LTD?

What the filing shows about KAZIA THERAPEUTICS LTD

65 investors had already put money in when it filed.
The filing names 7 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on KAZIA THERAPEUTICS LTD: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on KAZIA THERAPEUTICS LTD covers

The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21

A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind KAZIA THERAPEUTICS LTD: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

Cite this page

Permanent URL: https://mentionfox.com/funding/kazia-therapeutics-ltd-form-d-25000001

Last updated 2026-10-27

KAZIA THERAPEUTICS LTD raised $55.25M — SEC Form D filing, December 2025. MentionFox, 2026-10-27. https://mentionfox.com/funding/kazia-therapeutics-ltd-form-d-25000001

KAZIA THERAPEUTICS LTD — $55.25M Form D filing, December 2025

Key facts